Faithward Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Faithward Advisors's LLY Position: Q1 2026 in Review
Faithward Advisors increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $96.3K and bringing the position to 996 shares worth $916K. The position accounts for 0.13% of the portfolio, ranked #135.
Faithward Advisors first reported a position in LLY in Q1 2024 and has held it in 7 quarters since. The position peaked at $968K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Faithward Advisors held 996 shares of Eli Lilly worth $916K as of Q1 2026.
- Faithward Advisors bought 95 Eli Lilly shares in Q1 2026, an estimated $96.3K.
- Eli Lilly made up 0.13% of Faithward Advisors's portfolio in Q1 2026, its #135 holding.
- Faithward Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 7 quarters since.
- Faithward Advisors's Eli Lilly position peaked at $968K in Q4 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Faithward Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.